About

Thomas C. Freyman is the retired Executive Vice President, Finance and Administration of Abbott Laboratories, where he served as Chief Financial Officer beginning in 2001 and retired in 2017. He joined AbbVie's board in 2020 after serving as a director of Allergan from 2018 until AbbVie's acquisition of Allergan plc. Mr. Freyman chairs the Nominations & Governance committee and serves on the Compensation committee. He previously served as a director of Tenneco Inc. from 2013 to 2022 and Hanger, Inc. from 2017 to 2022.

Roles

AbbVie Inc.
Retired Executive Vice President, Finance and Administration, Abbott Laboratories · Current role
2020–present
Abbott Laboratories
Executive Vice President, Finance and Administration
2015 - 2017
Abbott Laboratories
Chief Financial Officer and Executive Vice President, Finance · First appointed CFO in 2001
2001 - 2015

External Roles

Allergan plc
Director
2018 - 2020
Tenneco Inc.
Director
2013 - 2022
Hanger, Inc.
Director
2017 - 2022

Director Compensation

FY 2025
Fees Earned or Paid in Cash
$147,917
Restricted Stock Unit Awards
$224,961

Also at AbbVie Inc.

Related

See how Top Bucket AI works for your firm

Request Demo
Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

✓

You're subscribed.

Thanks for signing up.